Association of antibiotic exposure with Kawasaki disease

Abstract Kawasaki disease (KD) is an acute febrile vasculitis of unknown etiology that primarily affects children under five years old. Emerging evidence suggests that gut microbiota alterations may contribute to KD pathogenesis. Because antibiotics modify intestinal microbial composition, their inappropriate or repeated use in early childhood may increase KD susceptibility. However, population-based evidence linking antibiotic exposure with KD onset remains limited, and the influence of antibiotic class, number of antibiotic prescriptions, and administration route has not been systematically evaluated. To examine the association between antibiotic type, number of antibiotic prescriptions, route of administration, and KD onset in a nationwide dataset. We conducted a matched case–control study using the JMDC database (2005–2024). Children aged 0–6 years were eligible. Newly diagnosed KD cases ( n = 17,410) and controls ( n = 68,621) were matched 1:4 by age, sex, and birth year. Antibiotic exposure from birth until one month before the index date was assessed by class (penicillins, cephalosporins, macrolides, quinolones, others), number of antibiotic prescriptions, and administration route (oral vs. intravenous). Multivariable conditional logistic regression estimated odds of KD onset adjusted for antiviral agent use, antifungal agent use, preterm birth, and low birth weight, with matching by age, sex, and birth year accounted for in the conditional analysis. Among 86,031 children, exposure to penicillins (OR, 1.27; 95% CI, 1.21–1.34), cephalosporins (OR, 1.16; 95% CI, 1.10–1.23), quinolones (OR, 1.48; 95% CI, 1.27–1.73), and macrolides (OR, 1.19; 95% CI, 1.09–1.31) was associated with increased KD risk. Higher odds of KD were observed with increasing numbers of antibiotic prescriptions (≥ 5 prescriptions: OR, 1.22; 95% CI, 1.16–1.28). Oral antibiotic use showed a significant association (OR, 1.22; 95% CI, 1.16–1.27), while intravenous use did not. Repeated antibiotic prescriptions, especially via oral administration, were associated with KD. These findings support an association between prior antibiotic exposure and KD, warranting further mechanistic investigation.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-10-28
DOI
https://doi.org/10.1038/s41598-026-74617-x
Primary Topic
Kawasaki Disease and Coronary Complications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of antibiotic exposure with Kawasaki disease

Arisa Kojima, Tetsushi Yoshikawa, Takanori Suzuki, Hidetoshi Uchida et al.
2 links
Scientific Reports
Kawasaki Disease and Coronary Complications
article

Association of antibiotic exposure with Kawasaki disease

Arisa Kojima, Tetsushi Yoshikawa, Takanori Suzuki, Hidetoshi Uchida, Nobuaki Michihata, Tadayoshi Hata, Jumpei Yoshida, Yumiko Asai, Kazuyoshi Saito
article en

Abstract

Abstract Kawasaki disease (KD) is an acute febrile vasculitis of unknown etiology that primarily affects children under five years old. Emerging evidence suggests that gut microbiota alterations may contribute to KD pathogenesis. Because antibiotics modify intestinal microbial composition, their inappropriate or repeated use in early childhood may increase KD susceptibility. However, population-based evidence linking antibiotic exposure with KD onset remains limited, and the influence of antibiotic class, number of antibiotic prescriptions, and administration route has not been systematically evaluated. To examine the association between antibiotic type, number of antibiotic prescriptions, route of administration, and KD onset in a nationwide dataset. We conducted a matched case–control study using the JMDC database (2005–2024). Children aged 0–6 years were eligible. Newly diagnosed KD cases ( n = 17,410) and controls ( n = 68,621) were matched 1:4 by age, sex, and birth year. Antibiotic exposure from birth until one month before the index date was assessed by class (penicillins, cephalosporins, macrolides, quinolones, others), number of antibiotic prescriptions, and administration route (oral vs. intravenous). Multivariable conditional logistic regression estimated odds of KD onset adjusted for antiviral agent use, antifungal agent use, preterm birth, and low birth weight, with matching by age, sex, and birth year accounted for in the conditional analysis. Among 86,031 children, exposure to penicillins (OR, 1.27; 95% CI, 1.21–1.34), cephalosporins (OR, 1.16; 95% CI, 1.10–1.23), quinolones (OR, 1.48; 95% CI, 1.27–1.73), and macrolides (OR, 1.19; 95% CI, 1.09–1.31) was associated with increased KD risk. Higher odds of KD were observed with increasing numbers of antibiotic prescriptions (≥ 5 prescriptions: OR, 1.22; 95% CI, 1.16–1.28). Oral antibiotic use showed a significant association (OR, 1.22; 95% CI, 1.16–1.27), while intravenous use did not. Repeated antibiotic prescriptions, especially via oral administration, were associated with KD. These findings support an association between prior antibiotic exposure and KD, warranting further mechanistic investigation.

Scientific Reports
Fujita Health University (JP), Hospital for Sick Children (CA), Kariya Toyota General Hospital (JP), The Cancer Institute Hospital (JP), Japanese Foundation For Cancer Research (JP), Chiba Cancer Center Research Institute (JP)
Japan Foundation for Pediatric Research
Good health and well-being
Openalex Percentile: Top 10%
Kawasaki Disease and Coronary Complications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon